Upstream Bio, Inc. (UPB)
1.59
-0.41
(-20.50%)
USD |
NASDAQ |
Nov 20, 16:00
1.62
+0.03
(+1.89%)
After-Hours: 20:00
Upstream Bio Shareholders Equity (Quarterly) : 233.98M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 233.98M |
| June 30, 2026 | 270.96M |
| March 31, 2026 | 304.00M |
| December 31, 2025 | 339.77M |
| September 30, 2025 | 378.58M |
| Date | Value |
|---|---|
| June 30, 2025 | 408.74M |
| March 31, 2025 | 445.61M |
| December 31, 2024 | 469.85M |
| September 30, 2024 | 220.56M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
| Arrowhead Pharmaceuticals, Inc. | 50.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 245.99M |
| Total Liabilities (Quarterly) | 12.02M |
| Debt to Equity Ratio | 0.0034 |
| Current Ratio | 20.45 |
| Net Debt Paydown Yield | 0.05% |